| ANOVA | Analysis of variance |
| APC | Allophycocyanin |
| DMSO | Dimethyl sulfoxide |
| DMAC | Dimethylacetamide |
| ECL | Enhanced chemiluminescence |
| FACS | Fluorescence-activated cell sorting |
| FBS | Fetal bovine serum |
| FGFR | Fibroblast growth factor receptor |
| FOXM1 | Forkhead box M1 |
| FRS2 | Fibroblast growth factor receptor substrate 2 |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase |
| GBM | Glioblastoma |
| GC1/GC2 | Glioblastoma stem cell lines 1 and 2 |
| GEPIA | Gene Expression Profiling Interactive Analysis |
| GSC | Glioblastoma stem cell |
| Gy | Gray (unit of irradiation) |
| HIF-1α | Hypoxia-inducible factor 1-alpha |
| IVIS | In vivo imaging system |
| MG132 | Proteasome inhibitor |
| MGMT | O6-methylguanine-DNA methyltransferase |
| mRNA | Messenger ribonucleic acid |
| PBS | Phosphate-buffered saline |
| PCR | Polymerase chain reaction |
| PE | Plating efficiency |
| Pem | Pemigatinib |
| qPCR | Quantitative polymerase chain reaction |
| RNA | Ribonucleic acid |
| RT | Reverse transcription |
| SD | Standard deviation |
| SFI | Specific fluorescence index |
| siRNA | Small interfering RNA |
| SNP | Single-nucleotide polymorphism |
| TCGA | The Cancer Genome Atlas |
| TMZ | Temozolomide |
| TTFields | Tumor Treating Fields |
| VUS | Variants of unknown significance |